{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:52:00Z","timestamp":1791813120325,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["23QA1411600"],"award-info":[{"award-number":["23QA1411600"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574032"],"award-info":[{"award-number":["82574032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304084"],"award-info":[{"award-number":["82304084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20254Y0022"],"award-info":[{"award-number":["20254Y0022"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112932","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:38:56Z","timestamp":1791319136000},"page":"112932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RIPK1 kinase and scaffold activities in tumor cell fate and therapy"],"prefix":"10.1016","volume":"149","author":[{"given":"Jingyu","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112932_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101748","article-title":"Receptor-interacting protein kinase 1 (RIPK1) regulates cervical cancer cells via NF-\u03baB-TNF-\u03b1 pathway: an in vitro study","volume":"36","author":"Bai","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0010","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1172\/JCI92508","article-title":"Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis","volume":"127","author":"Van","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2026.112932_bb0015","doi-asserted-by":"crossref","first-page":"14231","DOI":"10.1073\/pnas.2005353117","article-title":"Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma","volume":"117","author":"Tan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2026.112932_bb0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tibs.2021.12.004","article-title":"Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases","volume":"47","author":"Rucker","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0025","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41418-020-00629-3","article-title":"Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death","volume":"28","author":"Kist","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2026.112932_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071525","article-title":"Regulation of RIPK1 phosphorylation: implications for inflammation, cell death, and therapeutic interventions","volume":"12","author":"Du","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.cellsig.2026.112932_bb0035","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1016\/j.molcel.2024.10.002","article-title":"Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway","volume":"84","author":"Zhang","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","article-title":"Caspases in cell death, inflammation, and Pyroptosis","volume":"38","author":"Kesavardhana","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2005.01.003","article-title":"The RIP kinases: crucial integrators of cellular stress","volume":"30","author":"Meylan","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00663","article-title":"Comprehensive evolutionary analysis of lamprey TNFR-associated factors (TRAFs) and receptor-interacting protein kinase (RIPKs) and insights into the functional characterization of TRAF3\/6 and RIPK1","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0055","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1128\/MCB.19.10.6500","article-title":"Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-\u03baB","volume":"19","author":"Pazdernik","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bbrc.2006.06.118","article-title":"Truncated RIP3 (tRIP3) acts upstream of FADD to induce apoptosis in the human hepatocellular carcinoma cell line QGY-7703","volume":"347","author":"Feng","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","article-title":"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation","volume":"137","author":"Cho","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0070","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","article-title":"Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","article-title":"Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule","volume":"1","author":"Holler","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0080","article-title":"RIPK1 in necroptosis and recent progress in related pharmaceutics","volume":"16","author":"Yao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrm3683","article-title":"Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death","volume":"14","author":"Ofengeim","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0090","article-title":"RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0092-8674(95)90072-1","article-title":"RIP: a novel protein containing a death domain that interacts with Fas\/APO-1 (CD95) in yeast and causes cell death","volume":"81","author":"Stanger","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0100","doi-asserted-by":"crossref","first-page":"E2001","DOI":"10.1073\/pnas.1722013115","article-title":"Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis","volume":"115","author":"Meng","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2026.112932_bb0105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41467-020-15466-8","article-title":"Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation","volume":"11","author":"Laurien","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molcel.2018.01.027","article-title":"Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2","volume":"69","author":"Annibaldi","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036368","article-title":"Multitasking kinase RIPK1 regulates cell death and inflammation","volume":"12","author":"Newton","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0125","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1038\/s41467-024-51303-y","article-title":"The structure of mouse RIPK1 RHIM-containing domain as a homo-amyloid and in RIPK1\/RIPK3 complex","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0130","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cell.2018.03.032","article-title":"The structure of the Necrosome RIPK1-RIPK3 core, a human hetero-amyloid signaling complex","volume":"173","author":"Mompe\u00e1n","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0135","doi-asserted-by":"crossref","unstructured":"Fay EJ, Isterabadi K, Rezanka CM, et al Evolutionary and functional analyses reveal a role for the RHIM in tuning RIPK3 activity across vertebrates. eLife 13:RP102301. doi:https:\/\/doi.org\/10.7554\/eLife.102301.","DOI":"10.7554\/eLife.102301.3"},{"key":"10.1016\/j.cellsig.2026.112932_bb0140","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.immuni.2024.04.016","article-title":"The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation","volume":"57","author":"Imai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2026.112932_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","article-title":"Control of protein stability by post-translational modifications","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom15040549","article-title":"The role of post-translational modifications in necroptosis","volume":"15","author":"Xiao","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.cellsig.2026.112932_bb0155","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1038\/s41467-020-19935-y","article-title":"Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0160","article-title":"PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1","volume":"42","author":"Wang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2026.112932_bb0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tcb.2016.01.006","article-title":"Holding RIPK1 on the ubiquitin leash in TNFR1 signaling","volume":"26","author":"Peltzer","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0170","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1038\/s41467-019-12033-8","article-title":"K63-linked ubiquitination regulates RIPK1 kinase activity to prevent cell death during embryogenesis and inflammation","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0175","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1038\/s41467-025-62723-9","article-title":"Opposing regulation of the K63-linked polyubiquitination of RIPK3 by SMURF1 and USP5 in necroptosis","volume":"16","author":"Hwang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1067164","article-title":"Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells","volume":"13","author":"Blanchett","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0185","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ncb3614","article-title":"p38(MAPK)\/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection","volume":"19","author":"Menon","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0190","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abn1725","article-title":"Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1","volume":"380","author":"Zhang","year":"2023","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.cellsig.2026.112932_bb0195","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1038\/s41467-022-34080-4","article-title":"Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation","volume":"13","author":"Tu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117069","article-title":"ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis","volume":"240","author":"Shi","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0205","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1548-x","article-title":"Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis","volume":"574","author":"Newton","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112932_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","article-title":"Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease","volume":"577","author":"Lalaoui","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112932_bb0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cellsig.2026.112932_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41419-022-05524-y","article-title":"TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1\/RIPK3\/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer","volume":"14","author":"Lin","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112932_bb0225","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3748\/wjg.v30.i15.2155","article-title":"OSW-1 triggers necroptosis in colorectal cancer cells through the RIPK1\/RIPK3\/MLKL signaling pathway facilitated by the RIPK1-p62\/SQSTM1 complex","volume":"30","author":"Wang","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41419-021-04483-0","article-title":"SMYD2 targets RIPK1 and restricts TNF-induced apoptosis and necroptosis to support colon tumor growth","volume":"13","author":"Yu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112932_bb0235","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcmgh.2020.10.009","article-title":"The fragile X mental retardation protein regulates RIPK1 and colorectal Cancer resistance to necroptosis","volume":"11","author":"Di Grazia","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0240","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4103\/njcp.njcp_520_24","article-title":"Analysis of the histopathological characteristics and expression of RIPK1 and NF- \u03baB in cervical Cancer in Kumasi, Ghana","volume":"28","author":"Duduyemi","year":"2025","journal-title":"Niger. J. Clin. Pract."},{"key":"10.1016\/j.cellsig.2026.112932_bb0245","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.21037\/tcr-23-578","article-title":"Clinicopathological and prognosis significance of RIPK1 in patients with cervical squamous cell carcinoma: a retrospective cohort study","volume":"12","author":"Guo","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112932_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1110939","article-title":"RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro","volume":"13","author":"Vogelsang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00496","article-title":"Human papillomavirus downregulates the expression of IFITM1 and RIPK3 to escape from IFN\u03b3- and TNF\u03b1-mediated antiproliferative effects and necroptosis","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0260","first-page":"2594","article-title":"Receptor interacting protein 1 knockdown induces cell death in liver cancer by suppressing STAT3\/ATR activation in a p53-dependent manner","volume":"12","author":"Jung","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112932_bb0265","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2015.10.001","article-title":"NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis","volume":"28","author":"Kondylis","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13062-024-00489-8","article-title":"The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1","volume":"19","author":"Yang","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.cellsig.2026.112932_bb0275","doi-asserted-by":"crossref","first-page":"17956","DOI":"10.1038\/s41598-023-45005-6","article-title":"Identifying prognostic genes related PANoptosis in lung adenocarcinoma and developing prediction model based on bioinformatics analysis","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112932_bb0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41523-021-00261-5","article-title":"RIPK1 is a negative mediator in aquaporin 1-driven triple-negative breast carcinoma progression and metastasis","volume":"7","author":"Yin","year":"2021","journal-title":"NPJ breast cancer"},{"key":"10.1016\/j.cellsig.2026.112932_bb0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41419-023-05841-w","article-title":"RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112932_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.184","article-title":"Tubular epithelial cells in renal clear cell carcinoma express high RIPK1\/3 and show increased susceptibility to TNF receptor 1-induced necroptosis","volume":"7","author":"Al-Lamki","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112932_bb0295","article-title":"O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma","volume":"77","author":"Zeng","year":"2024","journal-title":"Drug resistance updates\u00a0: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.cellsig.2026.112932_bb0300","article-title":"Ficolin-3 activates complement and triggers necroptosis in cholangiocarcinoma cells via the RIPK1\/RIPK3\/MLKL signaling pathway","volume":"39","author":"Zhang","year":"2025","journal-title":"FASEB journal\u00a0: official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.cellsig.2026.112932_bb0305","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41467-025-56493-7","article-title":"A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development","volume":"16","author":"Schneider","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119064","article-title":"RIPK1 contributes to cisplatin-induced apoptosis of esophageal squamous cell carcinoma cells via activation of JNK pathway","volume":"269","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0315","unstructured":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury | Nature Chemical Biology. https:\/\/www.nature.com\/articles\/nchembio711. Accessed 10 Feb 2026."},{"key":"10.1016\/j.cellsig.2026.112932_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2026.112932_bb0325","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","article-title":"Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target","volume":"19","author":"Mifflin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2026.112932_bb0330","doi-asserted-by":"crossref","first-page":"807","DOI":"10.14336\/AD.2018.0728","article-title":"Necrostatin-1 prevents necroptosis in brains after ischemic stroke via inhibition of RIPK1-mediated RIPK3\/MLKL signaling","volume":"10","author":"Deng","year":"2019","journal-title":"Aging Dis."},{"key":"10.1016\/j.cellsig.2026.112932_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.176","article-title":"Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models","volume":"3","author":"Takahashi","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112932_bb0340","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1021\/acs.jmedchem.5b01898","article-title":"DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and Monoselective receptor interacting protein 1 kinase inhibitors","volume":"59","author":"Harris","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112932_bb0345","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/cddiscovery.2015.9","article-title":"Characterization of GSK\u2019963: a structurally distinct, potent and selective inhibitor of RIP1 kinase","volume":"1","author":"Berger","year":"2015","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cellsig.2026.112932_bb0350","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","article-title":"Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases","volume":"60","author":"Harris","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112932_bb0355","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000680","article-title":"A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis","volume":"8","author":"Weisel","year":"2021","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13318-020-00652-2","article-title":"Comparison of the pharmacokinetics of RIPK1 inhibitor GSK2982772 in healthy Western and Japanese subjects","volume":"46","author":"Tompson","year":"2021","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cellsig.2026.112932_bb0365","article-title":"Stage-dependent impact of RIPK1 inhibition on Atherogenesis: dual effects on inflammation and foam cell dynamics","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cellsig.2026.112932_bb0370","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2018.10.006","article-title":"RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic Cancer","volume":"34","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112932_bb0375","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","article-title":"RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases","volume":"27","author":"Patel","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2026.112932_bb0380","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/acs.jmedchem.7b01647","article-title":"Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships","volume":"61","author":"Yoshikawa","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112932_bb0385","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41419-019-1735-6","article-title":"Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis","volume":"10","author":"Hou","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112932_bb0390","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/intimm\/dxac061","article-title":"Repurposing crizotinib to target RIPK1-dependent cell death","volume":"35","author":"Yu","year":"2023","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0395","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/acs.jmedchem.6b01196","article-title":"Discovery of a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) for the treatment of systemic inflammatory response syndrome","volume":"60","author":"Ren","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112932_bb0400","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jointm.2024.07.003","article-title":"Safety and efficacy of selective RIPK1 inhibitor SIR1-365 in hospitalized patients with severe COVID-19: a multicenter, randomized, double-blind, phase 1b trial","volume":"5","author":"Chavez-Tapia","year":"2025","journal-title":"J. Intensive Med."},{"key":"10.1016\/j.cellsig.2026.112932_bb0405","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12931-024-02670-z","article-title":"Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study","volume":"25","author":"Clot","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.cellsig.2026.112932_bb0410","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1007\/s12325-025-03255-y","article-title":"A randomized phase I trial evaluating safety and pharmacokinetics of single and multiple ascending doses of Eclitasertib, a RIPK1 inhibitor, in healthy participants","volume":"42","author":"Farenc","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.cellsig.2026.112932_bb0415","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70151","article-title":"Safety, pharmacokinetics and target engagement of a novel brain penetrant RIPK1 inhibitor (SIR9900) in healthy adults and elderly participants","volume":"18","author":"Gonen","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0420","unstructured":"A Study to Assess the Effectiveness and Safety of SIR9900 in Patients With VEXAS Syndrome. In: CTIS.eu Clinical Trials. https:\/\/ctis.eu\/trial\/2025-524918-28-00. Accessed 26 Sept 2026."},{"key":"10.1016\/j.cellsig.2026.112932_bb0425","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cpt.1615","article-title":"DNL104, a centrally penetrant RIPK1 inhibitor, inhibits RIP1 kinase phosphorylation in a randomized phase I ascending dose study in healthy volunteers","volume":"107","author":"Grievink","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2026.112932_bb0430","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13690","article-title":"Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants","volume":"17","author":"Hincelin-Mery","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0435","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/cts.13580","article-title":"A phase I randomized, double-blinded, placebo-controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects","volume":"16","author":"Lickliter","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13857","article-title":"A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants","volume":"17","author":"Sun","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139238","article-title":"Synthesis and evaluation of hybrid molecules as RIPK1 and HDACs dual inhibitors","volume":"1318","author":"Tang","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cellsig.2026.112932_bb0450","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1038\/s41467-024-55006-2","article-title":"Development of a RIPK1 degrader to enhance antitumor immunity","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112932_bb0455","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112932_bb0460","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.immuni.2024.04.025","article-title":"A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death","volume":"57","author":"Mannion","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2026.112932_bb0465","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1021\/acsptsci.4c00421","article-title":"Targeted degradation of receptor-interacting protein kinase 1 to modulate the necroptosis pathway","volume":"7","author":"Inuzuka","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.cellsig.2026.112932_bb0470","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11030-025-11166-x","article-title":"Design, synthesis, and biological evaluation of RIPK1-targeting PROTACs","volume":"30","author":"Zhang","year":"2026","journal-title":"Mol. Divers."},{"key":"10.1016\/j.cellsig.2026.112932_bb0480","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.immuni.2022.03.007","article-title":"The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade","volume":"55","author":"Cucolo","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2026.112932_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114335","article-title":"The interaction between RIPK1 and FADD controls perinatal lethality and inflammation","volume":"43","author":"Rodriguez","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2026.112932_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030363","article-title":"Stem cell factor SOX9 interacts with a cell death regulator RIPK1 and results in escape of Cancer stem cell death","volume":"11","author":"Oh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cellsig.2026.112932_bb0495","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s13046-019-1423-5","article-title":"Necroptosis regulates tumor repopulation after radiotherapy via RIP1\/RIP3\/MLKL\/JNK\/IL8 pathway","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.cellsig.2026.112932_bb0500","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910979","article-title":"RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma","volume":"12","author":"Smith","year":"2020","journal-title":"EMBO Mol. Med."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:11:31Z","timestamp":1791810691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826005917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":99,"alternative-id":["S0898656826005917"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112932","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RIPK1 kinase and scaffold activities in tumor cell fate and therapy","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112932"}}